Publicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (14)

2024

  1. Surrogate endpoints in phase III randomized trials of advanced gastroesophageal cancer: A systematic review and meta-analysis

    Critical Reviews in Oncology/Hematology, Vol. 201

2023

  1. Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402

    Journal of the National Cancer Institute, Vol. 115, Núm. 12, pp. 1497-1505

2021

  1. Clinical impact of presurgery circulating tumor DNA after total neoadjuvant treatment in locally advanced rectal cancer: A biomarker study from the GEMCAD 1402 trial

    Clinical Cancer Research, Vol. 27, Núm. 10, pp. 2890-2898

2019

  1. Effect of Aflibercept Plus Modified FOLFOX6 Induction Chemotherapy before Standard Chemoradiotherapy and Surgery in Patients with High-Risk Rectal Adenocarcinoma: The GEMCAD 1402 Randomized Clinical Trial

    JAMA Oncology, Vol. 5, Núm. 11, pp. 1566-1573

  2. Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: The ULTRA trial

    Annals of Oncology, Vol. 30, Núm. 5, pp. 796-803

2018

  1. Genomic Profiling of HER2-Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2-Positive Advanced Gastric Cancer Treated with Trastuzumab

    Oncologist, Vol. 23, Núm. 9, pp. 1092-1102

2013

  1. Level of HER2 gene amplification predicts response and overall survival in her2-positive advanced gastric cancer treated with trastuzumab

    Journal of Clinical Oncology, Vol. 31, Núm. 35, pp. 4445-4452

2004

  1. Clinical significance of antinuclear antibodies in malignant diseases: Association with rheumatic and connective tissue paraneoplastic syndromes

    Lupus, Vol. 13, Núm. 3, pp. 159-164

1996

  1. Endobronchial metastatic disease: Analysis of 32 cases

    Journal of Surgical Oncology, Vol. 62, Núm. 4, pp. 249-252

1992

  1. Cavitary pulmonary metastases in transitional cell carcinoma of the urinary bladder

    Urologia Internationalis, Vol. 48, Núm. 1, pp. 102-104

  2. Interferon and disseminated langerhans cell histiocytosis

    Medical and Pediatric Oncology, Vol. 20, Núm. 4, pp. 336-337

  3. TRATAMIENTO DEL CARCINOMA DE CELULAS PEQUENAS DE PULMON LOCALIZADO CON CICLOFOSFAMIDA-ADRIAMICINA-ETOPOSIDO Y RADIOTERAPIA MEDIASTINICA

    Oncologia, Vol. 15, Núm. 9, pp. 414-418

1990

  1. HIPOMAGNESEMIA SINTOMATICA EN UN PACIENTE TRATADO CON CISPLATINO

    Medicina Clinica

  2. TRATAMIENTO CON INTERFERON DE LA HISTIOCITOSIS DE CELULAS DE LANGERHANS SISTEMICA EN UN ADULTO

    Medicina Clinica, Vol. 94, Núm. 5, pp. 184-186